SM
DMTK

SG3 Management’s DermTech, Inc. Common Stock DMTK Stock Holding History

SG3 Management’s Portfolio DMTK Stock Details DMTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-50,000
Closed -$734K – 927
2022
Q1 		$734K Buy
+50,000
New +$669K 0.02% 524

Other funds holding DMTK

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $2.18B AUM 0.03% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
LCM
Landscape Capital Management Englewood, New Jersey $1.58B AUM 26.88% 1-Year Est. Return

SG3 Management's DMTK Position: Q2 2022 in Review

SG3 Management sold out of DermTech, Inc. Common Stock (DMTK) in Q2 2022, closing a stake of 50,000 shares — an estimated $734K sold.

SG3 Management first reported a position in DMTK in Q1 2022 and held it in 1 quarter. The position peaked at $734K in Q1 2022. 134 funds tracked by Wall St. Rank hold DMTK as of Q2 2022.

  • SG3 Management reported no remaining DermTech, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • SG3 Management sold 50,000 DermTech, Inc. Common Stock shares in Q2 2022, an estimated $734K.
  • SG3 Management first reported a position in DermTech, Inc. Common Stock in Q1 2022 and held it in 1 quarter.
  • SG3 Management's DermTech, Inc. Common Stock position peaked at $734K in Q1 2022.
  • 134 funds tracked by Wall St. Rank held DermTech, Inc. Common Stock as of Q2 2022.

Based on SG3 Management's 13F filing for Q2 2022, filed 15 Aug 2022.